New changes have come into effect regarding the payment process for medicines and medical device registration and re-registration in Uzbekistan from 28 October 2024. All payments are now made in Uzbek sum based on a published official price list.

It is only the Marketing Authorisation Holder (MAH) or duly nominated under the power of attorney representative can act as an applicant in regulatory procedures. It is important to note that only the applicant with a valid Uzbekistan state digital signature can make the payment. The payment period is set at 60 days from the invoice date and under new regulations no contract for the procedure is issued any longer. Unlike previously, the state fees are now paid to the State Treasury of Uzbekistan and not to the Health Authority. These fees are also treated as state duties and are exempt from VAT.

Inpharmatis has now organised a fully operational legal entity in Tashkent in addition to its representative office of the Latvian headquarter. We actively respond to regulatory changes and continue expanding our team of experts in the region to provide reliable support to global pharmaceutical companies throughout regulatory processes.

Inpharmatis offers Clients high-quality and efficient services that meet the latest market requirements and can now support its Clients in local payment procedures in Uzbekistan.

For more detailed information and consultations, please contact us by info@inpharmatis.com.